Professor Jim Al-Khalili tells the electrifying story of our quest to master nature's most mysterious force - electricity. Until fairly recently, electricity was seen as a magical power, but it is now the lifeblood of the modern world and underpins every aspect of our technological advancements.Without electricity, we would be lost. This series tells of dazzling leaps of imagination and extraordinary experiments - a story of maverick geniuses who used electricity to light our cities, to communicate across the seas and through the air, to create modern industry and to give us the digital revolution. Episode one tells the story of the very first 'natural philosophers' who started to unlock the mysteries of electricity. They studied its curious link to life, built strange and powerful instruments to create it and even tamed lightning itself. It was these men who truly laid the foundations of the modern world. Electricity was without doubt a fantastical wonder. This is the story about what happened when the first real concerted effort was made to understand electricity; how we learned to create and store it, before finally creating something that enabled us to make it at will - the battery.

Since the original series went on the air in 1966, the Star Trek franchise has had a history of ups and downs in the toy business - from AMT's faithful scale model kit of the USS Enterprise to Remco's obscure tie-in merchandise, to Mego's best–selling action figure line. Following Mego's bankruptcy in 1983 and a string of flops by Ertl and Galoob, Playmates Toys picked up the toy license in the late 1980s and sparked a resurgence in the franchise's toy sales.
From the mid-2000s onwards, companies such as Art Asylum and McFarlane Toys continue to keep the Star Trek toy franchise alive.

In this curious series, the minds behind history's most iconic toy franchises will discuss the rise (and sometimes fall) of their billion-dollar creations.
In 1977, after being rejected by Mattel and Hasbro, Lucasfilm signed with Kenner Products to have toys produced for their sci-fi film Star Wars. This was a huge gamble, as Kenner was a small toy company at the time and the negotiation process started late due to George Lucas' secrecy over the ship designs. Since then, toy sales of the Star Wars franchise have totaled to US$14 billion worldwide.

One man's journey to discover the bitter truth about sugar. Damon Gameau embarks on a unique experiment to document the effects of a high sugar diet on a healthy body, consuming only foods that are commonly perceived as 'healthy'. Through this entertaining and informative journey, Damon highlights some of the issues that plague the sugar industry, and where sugar lurks on supermarket shelves. This will change the way you think about healthy food.

The film looks at the concept of the corporation throughout recent history up to its present-day dominance. Since the late 18th century American legal decision that the business corporation organizational model is legally a person, it has become a dominant economic, political and social force around the globe.
This documentary takes an in-depth psychological examination of the organization model through various case studies. What the study illustrates is that in the its behaviour, this type of 'person' typically acts like a dangerously destructive psychopath without conscience. Furthermore, we see the profound threat this psychopath has for our world and our future, but also how the people with courage, intelligence and determination can do to stop it.

This series is a searing indictment of Big Pharma and the political operatives and government regulations that enable over-production, reckless distribution and abuse of synthetic opiates. Exploring the origins, extent and fallout of one of the most devastating public health tragedies of our time, with half a million deaths from overdoses this century alone, the film reveals that America's opioid epidemic is not a public health crisis that came out of nowhere.
In the first part, a look at how Purdue Pharma worked with the FDA to get OxyContin approved for wider use, promoting the highly profitable pain medication's safety without sufficient evidence, and creating a campaign to redefine pain and how it's treated.